Digestives & Intestinal Remedies - Iraq

  • Iraq
  • In Iraq, the revenue generated in the Digestives & Intestinal Remedies market market is estimated to be US$61.44m in 2024.
  • It is projected to experience an annual growth rate of 0.56% (CAGR 2024-2029).
  • When compared to other countries worldwide, in China generates the highest revenue in this market, amounting to US$4,408.00m in 2024.
  • In terms of per capita figures, the revenue per person in Iraq is US$1.32 in 2024.
  • The demand for Digestives & Intestinal Remedies in Iraq has been steadily increasing due to the country's high prevalence of digestive health issues.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Iraq is experiencing steady growth due to increasing customer preferences for natural and herbal remedies, as well as the rising prevalence of digestive disorders in the country.

Customer preferences:
In Iraq, consumers are increasingly favoring natural and herbal remedies for digestive issues. This shift in preference can be attributed to the growing awareness about the potential side effects of conventional medications and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for products that contain natural ingredients such as ginger, peppermint, and chamomile, which are known for their digestive benefits.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in Iraq is the increasing availability of over-the-counter (OTC) products. Previously, consumers had limited access to these products, as they were primarily available through prescription. However, with the expansion of the retail sector and the establishment of more pharmacies, OTC products have become more accessible to the general population. This has contributed to the growth of the market, as consumers now have the option to purchase these remedies without the need for a doctor's prescription.Another trend in the market is the rising demand for probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They can help restore the natural balance of bacteria in the gut and alleviate symptoms of digestive disorders. The increasing awareness about the importance of gut health and the positive effects of probiotics has led to a surge in demand for probiotic supplements and foods in Iraq.

Local special circumstances:
Iraq faces unique challenges in the Digestives & Intestinal Remedies market due to the ongoing political instability and security concerns in the country. These factors have hindered the growth of the healthcare sector and limited the availability of healthcare facilities and services. However, despite these challenges, the market for Digestives & Intestinal Remedies has shown resilience and continues to grow.

Underlying macroeconomic factors:
The growth of the Digestives & Intestinal Remedies market in Iraq can be attributed to several underlying macroeconomic factors. The increasing disposable income and improving living standards of the population have made healthcare more affordable and accessible. Additionally, the growing urbanization and changing lifestyles, including dietary habits, have contributed to the rising prevalence of digestive disorders in the country. These factors, combined with the increasing awareness about natural remedies and the availability of OTC products, have created a favorable environment for the growth of the market.In conclusion, the Digestives & Intestinal Remedies market in Iraq is experiencing steady growth driven by customer preferences for natural and herbal remedies, the increasing availability of OTC products, and the rising prevalence of digestive disorders. Despite the unique challenges posed by political instability and security concerns, the market continues to expand due to underlying macroeconomic factors such as increasing disposable income and changing lifestyles.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)